SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000944809-21-000040
Filing Date
2021-06-21
Accepted
2021-06-21 16:08:05
Documents
14
Period of Report
2021-06-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opk-20210618.htm   iXBRL 8-K 45376
2 EX-99.1 a991pressrelease61821.htm EX-99.1 16077
6 GRAPHIC image_0.jpg GRAPHIC 260383
  Complete submission text file 0000944809-21-000040.txt   562928

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20210618.xsd EX-101.SCH 1900
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20210618_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20210618_pre.xml EX-101.PRE 12511
7 EXTRACTED XBRL INSTANCE DOCUMENT opk-20210618_htm.xml XML 10752
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 211030577
SIC: 2834 Pharmaceutical Preparations